Dermal Filler and Botolinum Toxin Market

List of Tables
Table 1. Dermal Filler and Botolinum Toxin CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Dermal Filler and Botolinum Toxin Market Trends
Table 3. Dermal Filler and Botolinum Toxin Market Drivers
Table 4. Dermal Filler and Botolinum Toxin Market Challenges
Table 5. Dermal Filler and Botolinum Toxin Market Restraints
Table 6. Global Dermal Filler and Botolinum Toxin Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Dermal Filler and Botolinum Toxin Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Dermal Filler and Botolinum Toxin Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Dermal Filler and Botolinum Toxin Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Dermal Filler and Botolinum Toxin Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Dermal Filler and Botolinum Toxin Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Dermal Filler and Botolinum Toxin Revenue Share by Manufacturer, 2017-2022
Table 13. Global Dermal Filler and Botolinum Toxin Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global Dermal Filler and Botolinum Toxin Sales Share by Manufacturer, 2017-2022
Table 15. Global Dermal Filler and Botolinum Toxin Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Dermal Filler and Botolinum Toxin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Dermal Filler and Botolinum Toxin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermal Filler and Botolinum Toxin as of 2021)
Table 18. Top Players of Dermal Filler and Botolinum Toxin in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Dermal Filler and Botolinum Toxin Product Type
Table 20. Date of International Manufacturers Enter into Dermal Filler and Botolinum Toxin Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Dermal Filler and Botolinum Toxin Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Dermal Filler and Botolinum Toxin Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Dermal Filler and Botolinum Toxin Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Dermal Filler and Botolinum Toxin Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States Dermal Filler and Botolinum Toxin Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Dermal Filler and Botolinum Toxin Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Dermal Filler and Botolinum Toxin Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global Dermal Filler and Botolinum Toxin Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global Dermal Filler and Botolinum Toxin Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Dermal Filler and Botolinum Toxin Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Dermal Filler and Botolinum Toxin Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America Dermal Filler and Botolinum Toxin Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Dermal Filler and Botolinum Toxin Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific Dermal Filler and Botolinum Toxin Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Dermal Filler and Botolinum Toxin Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe Dermal Filler and Botolinum Toxin Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Dermal Filler and Botolinum Toxin Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa Dermal Filler and Botolinum Toxin Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Dermal Filler and Botolinum Toxin Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa Dermal Filler and Botolinum Toxin Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Allergan Corporation Information
Table 43. Allergan Description and Business Overview
Table 44. Allergan Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. Allergan Dermal Filler and Botolinum Toxin Product
Table 46. Allergan Recent Development
Table 47. Galderma Corporation Information
Table 48. Galderma Description and Business Overview
Table 49. Galderma Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. Galderma Product
Table 51. Galderma Recent Development
Table 52. Merz Pharma GmbH & Co. KGaA Corporation Information
Table 53. Merz Pharma GmbH & Co. KGaA Description and Business Overview
Table 54. Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Merz Pharma GmbH & Co. KGaA Product
Table 56. Merz Pharma GmbH & Co. KGaA Recent Development
Table 57. Anika Therapeutics Corporation Information
Table 58. Anika Therapeutics Description and Business Overview
Table 59. Anika Therapeutics Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. Anika Therapeutics Product
Table 61. Anika Therapeutics Recent Development
Table 62. Suneva Medical Corporation Information
Table 63. Suneva Medical Description and Business Overview
Table 64. Suneva Medical Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. Suneva Medical Product
Table 66. Suneva Medical Recent Development
Table 67. Contura Corporation Information
Table 68. Contura Description and Business Overview
Table 69. Contura Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 70. Contura Product
Table 71. Contura Recent Development
Table 72. HUGEL Corporation Information
Table 73. HUGEL Description and Business Overview
Table 74. HUGEL Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 75. HUGEL Product
Table 76. HUGEL Recent Development
Table 77. Grex Pharma Corporation Information
Table 78. Grex Pharma Description and Business Overview
Table 79. Grex Pharma Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 80. Grex Pharma Product
Table 81. Grex Pharma Recent Development
Table 82. Daewoong Pharmaceuticals Corporation Information
Table 83. Daewoong Pharmaceuticals Description and Business Overview
Table 84. Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 85. Daewoong Pharmaceuticals Product
Table 86. Daewoong Pharmaceuticals Recent Development
Table 87. Medy-Tox Corporation Information
Table 88. Medy-Tox Description and Business Overview
Table 89. Medy-Tox Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 90. Medy-Tox Product
Table 91. Medy-Tox Recent Development
Table 92. TEOXANE Laboratories Corporation Information
Table 93. TEOXANE Laboratories Description and Business Overview
Table 94. TEOXANE Laboratories Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 95. TEOXANE Laboratories Product
Table 96. TEOXANE Laboratories Recent Development
Table 97. SciVision Biotech Corporation Information
Table 98. SciVision Biotech Description and Business Overview
Table 99. SciVision Biotech Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 100. SciVision Biotech Product
Table 101. SciVision Biotech Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Dermal Filler and Botolinum Toxin Customers List
Table 105. Dermal Filler and Botolinum Toxin Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Dermal Filler and Botolinum Toxin Product Picture
Figure 2. Global Dermal Filler and Botolinum Toxin Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Dermal Filler and Botolinum Toxin Market Size 2017-2028 (US$ Million)
Figure 4. Global Dermal Filler and Botolinum Toxin Sales 2017-2028 (K MT)
Figure 5. United States Dermal Filler and Botolinum Toxin Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Dermal Filler and Botolinum Toxin Market Size 2017-2028 (US$ Million)
Figure 7. United States Dermal Filler and Botolinum Toxin Sales 2017-2028 (K MT)
Figure 8. United States Dermal Filler and Botolinum Toxin Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Dermal Filler and Botolinum Toxin Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. Dermal Filler and Botolinum Toxin Report Years Considered
Figure 11. Product Picture of Hyaluronic Acid Based Fillers
Figure 12. Product Picture of Non-Hyaluronic Acid Based Fillers
Figure 13. Product Picture of Botulinum Toxin
Figure 14. Global Dermal Filler and Botolinum Toxin Market Share by Type in 2022 & 2028
Figure 15. Global Dermal Filler and Botolinum Toxin Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Dermal Filler and Botolinum Toxin Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Dermal Filler and Botolinum Toxin Sales by Type (2017-2028) & (K MT)
Figure 18. Global Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Dermal Filler and Botolinum Toxin Price by Type (2017-2028) & (USD/MT)
Figure 20. United States Dermal Filler and Botolinum Toxin Market Share by Type in 2022 & 2028
Figure 21. United States Dermal Filler and Botolinum Toxin Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Dermal Filler and Botolinum Toxin Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Dermal Filler and Botolinum Toxin Sales by Type (2017-2028) & (K MT)
Figure 24. United States Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Dermal Filler and Botolinum Toxin Price by Type (2017-2028) & (USD/MT)
Figure 26. Product Picture of Aesthetic Restoration
Figure 27. Product Picture of Wrinkle Reduction
Figure 28. Global Dermal Filler and Botolinum Toxin Market Share by Application in 2022 & 2028
Figure 29. Global Dermal Filler and Botolinum Toxin Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Dermal Filler and Botolinum Toxin Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Dermal Filler and Botolinum Toxin Sales by Application (2017-2028) & (K MT)
Figure 32. Global Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Dermal Filler and Botolinum Toxin Price by Application (2017-2028) & (USD/MT)
Figure 34. United States Dermal Filler and Botolinum Toxin Market Share by Application in 2022 & 2028
Figure 35. United States Dermal Filler and Botolinum Toxin Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Dermal Filler and Botolinum Toxin Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Dermal Filler and Botolinum Toxin Sales by Application (2017-2028) & (K MT)
Figure 38. United States Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Dermal Filler and Botolinum Toxin Price by Application (2017-2028) & (USD/MT)
Figure 40. North America Dermal Filler and Botolinum Toxin Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 41. North America Dermal Filler and Botolinum Toxin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Dermal Filler and Botolinum Toxin Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 45. Europe Dermal Filler and Botolinum Toxin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Dermal Filler and Botolinum Toxin Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 52. Asia-Pacific Dermal Filler and Botolinum Toxin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Dermal Filler and Botolinum Toxin Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 64. Latin America Dermal Filler and Botolinum Toxin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Dermal Filler and Botolinum Toxin Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 69. Middle East & Africa Dermal Filler and Botolinum Toxin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. U.A.E Dermal Filler and Botolinum Toxin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Dermal Filler and Botolinum Toxin Value Chain
Figure 74. Dermal Filler and Botolinum Toxin Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed